» Articles » PMID: 6141395

Scintigraphic Imaging of Neuroblastoma with [131-I]iodobenzylguanidine

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 1984 Feb 11
PMID 6141395
Citations 34
Authors
Affiliations
Soon will be listed here.
Citing Articles

Hybrid Molecules of Benzylguanidine and the Alkylating Group of Melphalan: Synthesis and Effects on Neuroblastoma Cells.

Bruchelt G, Klose C, Lischka M, Brandes M, Handgretinger R, Brueckner R J Clin Med. 2023; 12(13).

PMID: 37445504 PMC: 10342853. DOI: 10.3390/jcm12134469.


A model of modified -iodobenzylguanidine conjugated gold nanoparticles for neuroblastoma treatment.

Saimuang K, Suttisintong K, Kaewchangwat N, Thanayupong E, Wongngam Y, Charoenphun P RSC Adv. 2022; 11(41):25199-25206.

PMID: 35478920 PMC: 9037022. DOI: 10.1039/d1ra04054e.


Upfront consolidation treatment with I-mIbG followed by myeloablative chemotherapy and hematopoietic stem cell transplantation in high-risk neuroblastoma.

Feng J, Cheng F, Leung A, Lee V, Yeung E, Ching Lam H Pediatr Investig. 2020; 4(3):168-177.

PMID: 33150310 PMC: 7520103. DOI: 10.1002/ped4.12216.


Targeting uptake transporters for cancer imaging and treatment.

Zhang Y, Wang J Acta Pharm Sin B. 2020; 10(1):79-90.

PMID: 31993308 PMC: 6977162. DOI: 10.1016/j.apsb.2019.12.005.


Current Consensus on I-131 MIBG Therapy.

Kayano D, Kinuya S Nucl Med Mol Imaging. 2018; 52(4):254-265.

PMID: 30100938 PMC: 6066492. DOI: 10.1007/s13139-018-0523-z.